Using mTOR Inhibitors in the Prevention of BK Nephropathy
Completed · Not applicable
Conditions studied: BK Viremia, BK Nephropathy
In brief
BK virus infections after kidney transplant are increasing and can result in damage to the transplanted kidney. Currently, the universally accepted treatment is to decrease the strength of the antirejection medications but it is unclear what medications should be lowered and to what extent. The investigators propose to perform a study with patients who have BK virus detected in their blood during routine screening that appears to be increasing. The investigators will use two different strategies that involve different combinations of standard anti-rejection medications at lower dosages. Patients will be assigned to one of the two groups in a random manner across the two hospitals participating in the study. Patients will be followed for at least a year to determine if one strategy was more effective than the other in preventing an increase in the number of viruses in the blood stream and whether either one was more effective in reducing the negative impact of the infection on the functioning of the transplanted kidney.
Key facts
- Study ID
- NCT01649609
- Run by
- Columbia University
- People needed
- 40
- Starts
- 2012-03-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2018-02-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Renal transplant recipients age 18 years or over
You may not qualify if…
- Patients with multiorgan transplants
- Patients on immunosuppressive regimens that include steroids or Sirolimus at the time of detection of viremia
- ABO incompatible renal transplants
- Three or more previous renal transplants
- Patients with contraindications to tacrolimus, sirolimus, mycophenolate mofetil or mycophenolic acid.
Where it is running
- Columbia University Medical Center — New York, New York, United States
- Weill Cornell Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.